메뉴 건너뛰기




Volumn 443, Issue , 2015, Pages 48-56

Galectin-3 and heart failure: Prognosis, prediction & clinical utility

Author keywords

Biomarker; Galectin 3; Heart failure; Prognosis; Review

Indexed keywords

BIOLOGICAL MARKER; GALECTIN 3; GALECTIN-3, HUMAN;

EID: 84924252300     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.10.009     Document Type: Article
Times cited : (57)

References (77)
  • 1
    • 0034110023 scopus 로고    scopus 로고
    • Epidemiology, aetiology, and prognosis of heart failure
    • McMurray J.J., Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart May 2000, 83(5):596-602.
    • (2000) Heart , vol.83 , Issue.5 , pp. 596-602
    • McMurray, J.J.1    Stewart, S.2
  • 2
    • 84857036974 scopus 로고    scopus 로고
    • Recent advances in the management of chronic heart failure
    • Haddad H., Mielniczuk L., Davies R.A. Recent advances in the management of chronic heart failure. Curr Opin Cardiol Mar 2012, 27(2):161-168.
    • (2012) Curr Opin Cardiol , vol.27 , Issue.2 , pp. 161-168
    • Haddad, H.1    Mielniczuk, L.2    Davies, R.A.3
  • 3
    • 0037058826 scopus 로고    scopus 로고
    • Lifetime risk for developing congestive heart failure: the Framingham Heart Study
    • Lloyd-Jones D.M., Larson M.G., Leip E.P., Beiser A., D'Agostino R.B., Kannel W.B., et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation Dec 10 2002, 106(24):3068-3072.
    • (2002) Circulation , vol.106 , Issue.24 , pp. 3068-3072
    • Lloyd-Jones, D.M.1    Larson, M.G.2    Leip, E.P.3    Beiser, A.4    D'Agostino, R.B.5    Kannel, W.B.6
  • 4
    • 69049099994 scopus 로고    scopus 로고
    • Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives
    • Neumann T., Biermann J., Erbel R., Neumann A., Wasem J., Ertl G., et al. Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int Apr 2009, 106(16):269-275.
    • (2009) Dtsch Arztebl Int , vol.106 , Issue.16 , pp. 269-275
    • Neumann, T.1    Biermann, J.2    Erbel, R.3    Neumann, A.4    Wasem, J.5    Ertl, G.6
  • 5
    • 77649091020 scopus 로고    scopus 로고
    • Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association
    • Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., et al. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation Feb 23 2010, 121(7):948-954.
    • (2010) Circulation , vol.121 , Issue.7 , pp. 948-954
    • Lloyd-Jones, D.1    Adams, R.J.2    Brown, T.M.3    Carnethon, M.4    Dai, S.5    De Simone, G.6
  • 6
    • 84872172492 scopus 로고    scopus 로고
    • Aging of the United States population: impact on heart failure
    • Vigen R., Maddox T.M., Allen L.A. Aging of the United States population: impact on heart failure. Curr Heart Fail Rep Dec 2012, 9(4):369-374.
    • (2012) Curr Heart Fail Rep , vol.9 , Issue.4 , pp. 369-374
    • Vigen, R.1    Maddox, T.M.2    Allen, L.A.3
  • 7
    • 84879202874 scopus 로고    scopus 로고
    • Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association
    • Heidenreich P.A., Albert N.M., Allen L.A., Bluemke D.A., Butler J., Fonarow G.C., et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail May 2013, 6(3):606-619.
    • (2013) Circ Heart Fail , vol.6 , Issue.3 , pp. 606-619
    • Heidenreich, P.A.1    Albert, N.M.2    Allen, L.A.3    Bluemke, D.A.4    Butler, J.5    Fonarow, G.C.6
  • 8
    • 84877246724 scopus 로고    scopus 로고
    • Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH
    • van der Velde A.R., Gullestad L., Ueland T., Aukrust P., Guo Y., Adourian A., et al. Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH. Circ Heart Fail Mar 2013, 6(2):219-226.
    • (2013) Circ Heart Fail , vol.6 , Issue.2 , pp. 219-226
    • van der Velde, A.R.1    Gullestad, L.2    Ueland, T.3    Aukrust, P.4    Guo, Y.5    Adourian, A.6
  • 9
    • 76449120415 scopus 로고    scopus 로고
    • N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study
    • Berger R., Moertl D., Peter S., Ahmadi R., Huelsmann M., Yamuti S., et al. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol Feb 16 2010, 55(7):645-653.
    • (2010) J Am Coll Cardiol , vol.55 , Issue.7 , pp. 645-653
    • Berger, R.1    Moertl, D.2    Peter, S.3    Ahmadi, R.4    Huelsmann, M.5    Yamuti, S.6
  • 10
    • 84864477617 scopus 로고    scopus 로고
    • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
    • McMurray J.J., Adamopoulos S., Anker S.D., Auricchio A., Bohm M., Dickstein K., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail Aug 2012, 14(8):803-869.
    • (2012) Eur J Heart Fail , vol.14 , Issue.8 , pp. 803-869
    • McMurray, J.J.1    Adamopoulos, S.2    Anker, S.D.3    Auricchio, A.4    Bohm, M.5    Dickstein, K.6
  • 11
    • 0037374349 scopus 로고    scopus 로고
    • B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study
    • McCullough P.A., Duc P., Omland T., McCord J., Nowak R.M., Hollander J.E., et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis Mar 2003, 41(3):571-579.
    • (2003) Am J Kidney Dis , vol.41 , Issue.3 , pp. 571-579
    • McCullough, P.A.1    Duc, P.2    Omland, T.3    McCord, J.4    Nowak, R.M.5    Hollander, J.E.6
  • 13
  • 15
    • 0031231651 scopus 로고    scopus 로고
    • Mapping of the galectin-3 gene (LGALS3) to human chromosome 14 at region 14q21-22
    • Raimond J., Zimonjic D.B., Mignon C., Mattei M., Popescu N.C., Monsigny M., et al. Mapping of the galectin-3 gene (LGALS3) to human chromosome 14 at region 14q21-22. Mamm Genome Sep 1997, 8(9):706-707.
    • (1997) Mamm Genome , vol.8 , Issue.9 , pp. 706-707
    • Raimond, J.1    Zimonjic, D.B.2    Mignon, C.3    Mattei, M.4    Popescu, N.C.5    Monsigny, M.6
  • 16
  • 17
    • 0028874589 scopus 로고
    • Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages
    • Liu F.T., Hsu D.K., Zuberi R.I., Kuwabara I., Chi E.Y., Henderson W.R. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol Oct 1995, 147(4):1016-1028.
    • (1995) Am J Pathol , vol.147 , Issue.4 , pp. 1016-1028
    • Liu, F.T.1    Hsu, D.K.2    Zuberi, R.I.3    Kuwabara, I.4    Chi, E.Y.5    Henderson, W.R.6
  • 18
    • 67649831425 scopus 로고    scopus 로고
    • The regulation of inflammation by galectin-3
    • Henderson N.C., Sethi T. The regulation of inflammation by galectin-3. Immunol Rev Jul 2009, 230(1):160-171.
    • (2009) Immunol Rev , vol.230 , Issue.1 , pp. 160-171
    • Henderson, N.C.1    Sethi, T.2
  • 19
    • 33847347313 scopus 로고    scopus 로고
    • ECM remodeling in hypertensive heart disease
    • Berk B.C., Fujiwara K., Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest Mar 2007, 117(3):568-575.
    • (2007) J Clin Invest , vol.117 , Issue.3 , pp. 568-575
    • Berk, B.C.1    Fujiwara, K.2    Lehoux, S.3
  • 21
    • 20844462878 scopus 로고    scopus 로고
    • Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction
    • Sharma U.C., Pokharel S., van Brakel T.J., van Berlo J.H., Cleutjens J.P., Schroen B., et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation Nov 9 2004, 110(19):3121-3128.
    • (2004) Circulation , vol.110 , Issue.19 , pp. 3121-3128
    • Sharma, U.C.1    Pokharel, S.2    van Brakel, T.J.3    van Berlo, J.H.4    Cleutjens, J.P.5    Schroen, B.6
  • 22
    • 61949375975 scopus 로고    scopus 로고
    • N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin
    • Liu Y.H., D'Ambrosio M., Liao T.D., Peng H., Rhaleb N.E., Sharma U., et al. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin. Am J Physiol Heart Circ Physiol Feb 2009, 296(2):H404-H412.
    • (2009) Am J Physiol Heart Circ Physiol , vol.296 , Issue.2 , pp. H404-H412
    • Liu, Y.H.1    D'Ambrosio, M.2    Liao, T.D.3    Peng, H.4    Rhaleb, N.E.5    Sharma, U.6
  • 23
    • 84873622349 scopus 로고    scopus 로고
    • Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis
    • Yu L., Ruifrok W.P., Meissner M., Bos E.M., van Goor H., Sanjabi B., et al. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis. Circ Heart Fail Jan 2013, 6(1):107-117.
    • (2013) Circ Heart Fail , vol.6 , Issue.1 , pp. 107-117
    • Yu, L.1    Ruifrok, W.P.2    Meissner, M.3    Bos, E.M.4    van Goor, H.5    Sanjabi, B.6
  • 27
    • 39549100788 scopus 로고    scopus 로고
    • Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis
    • Henderson N.C., Mackinnon A.C., Farnworth S.L., Kipari T., Haslett C., Iredale J.P., et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol Feb 2008, 172(2):288-298.
    • (2008) Am J Pathol , vol.172 , Issue.2 , pp. 288-298
    • Henderson, N.C.1    Mackinnon, A.C.2    Farnworth, S.L.3    Kipari, T.4    Haslett, C.5    Iredale, J.P.6
  • 29
    • 77951206972 scopus 로고    scopus 로고
    • Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure
    • Christenson R.H., Duh S.H., Wu A.H., Smith A., Abel G., deFilippi C.R., et al. Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure. Clin Biochem May 2010, 43(7-8):683-690.
    • (2010) Clin Biochem , vol.43 , Issue.7-8 , pp. 683-690
    • Christenson, R.H.1    Duh, S.H.2    Wu, A.H.3    Smith, A.4    Abel, G.5    deFilippi, C.R.6
  • 30
    • 84896902187 scopus 로고    scopus 로고
    • The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure
    • Meijers W.C., van der Velde A.R., de Boer R.A. The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure. Expert Rev Mol Diagn 2014, 14(3):257-266.
    • (2014) Expert Rev Mol Diagn , vol.14 , Issue.3 , pp. 257-266
    • Meijers, W.C.1    van der Velde, A.R.2    de Boer, R.A.3
  • 31
    • 84891696028 scopus 로고    scopus 로고
    • Galectin-3 testing: validity of a novel automated assay in heart failure patients with reduced ejection fraction
    • Gruson D., Mancini M., Ahn S.A., Rousseau M.F. Galectin-3 testing: validity of a novel automated assay in heart failure patients with reduced ejection fraction. Clin Chim Acta Feb 15 2014, 429:189-193.
    • (2014) Clin Chim Acta , vol.429 , pp. 189-193
    • Gruson, D.1    Mancini, M.2    Ahn, S.A.3    Rousseau, M.F.4
  • 32
    • 84879467972 scopus 로고    scopus 로고
    • Heart Failure Association of the European Society of Cardiology (HFA). EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
    • Maggioni A.P., Dahlström U., Filippatos G., Chioncel O., Crespo Leiro M., Drozdz J., et al. Heart Failure Association of the European Society of Cardiology (HFA). EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2013, 15(7):808-817.
    • (2013) Eur J Heart Fail , vol.15 , Issue.7 , pp. 808-817
    • Maggioni, A.P.1    Dahlström, U.2    Filippatos, G.3    Chioncel, O.4    Crespo Leiro, M.5    Drozdz, J.6
  • 33
    • 33751059230 scopus 로고    scopus 로고
    • Congestion in acute heart failure syndromes: an essential target of evaluation and treatment
    • Gheorghiade M., Filippatos G., De Luca L., Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med Dec 2006, 119(12 Suppl 1):S3-S10.
    • (2006) Am J Med , vol.119 , Issue.12 , pp. S3-S10
    • Gheorghiade, M.1    Filippatos, G.2    De Luca, L.3    Burnett, J.4
  • 34
    • 84871912144 scopus 로고    scopus 로고
    • Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization
    • Collins S.P., Pang P.S., Fonarow G.C., Yancy C.W., Bonow R.O., Gheorghiade M. Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization. J Am Coll Cardiol Jan 15 2013, 61(2):121-126.
    • (2013) J Am Coll Cardiol , vol.61 , Issue.2 , pp. 121-126
    • Collins, S.P.1    Pang, P.S.2    Fonarow, G.C.3    Yancy, C.W.4    Bonow, R.O.5    Gheorghiade, M.6
  • 35
    • 84901434162 scopus 로고    scopus 로고
    • Emergency department use of galectin-3
    • Peacock W.F., DiSomma S. Emergency department use of galectin-3. Crit Pathw Cardiol Jun 2014, 13(2):73-77.
    • (2014) Crit Pathw Cardiol , vol.13 , Issue.2 , pp. 73-77
    • Peacock, W.F.1    DiSomma, S.2
  • 36
    • 33748415221 scopus 로고    scopus 로고
    • Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure
    • van Kimmenade R.R., Januzzi J.L., Ellinor P.T., Sharma U.C., Bakker J.A., Low A.F., et al. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol Sep 19 2006, 48(6):1217-1224.
    • (2006) J Am Coll Cardiol , vol.48 , Issue.6 , pp. 1217-1224
    • van Kimmenade, R.R.1    Januzzi, J.L.2    Ellinor, P.T.3    Sharma, U.C.4    Bakker, J.A.5    Low, A.F.6
  • 37
    • 78651387589 scopus 로고    scopus 로고
    • Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
    • de Boer R.A., Lok D.J., Jaarsma T., van der Meer P., Voors A.A., Hillege H.L., et al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med Feb 2011, 43(1):60-68.
    • (2011) Ann Med , vol.43 , Issue.1 , pp. 60-68
    • de Boer, R.A.1    Lok, D.J.2    Jaarsma, T.3    van der Meer, P.4    Voors, A.A.5    Hillege, H.L.6
  • 39
    • 84901780251 scopus 로고    scopus 로고
    • Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials
    • Meijers W.C., Januzzi J.L., deFilippi C., Adourian A.S., Shah S.J., van Veldhuisen D.J., et al. Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials. Am Heart J Jun 2014, 167(6):853-860. [e4.].
    • (2014) Am Heart J , vol.167 , Issue.6 , pp. 853-860
    • Meijers, W.C.1    Januzzi, J.L.2    deFilippi, C.3    Adourian, A.S.4    Shah, S.J.5    van Veldhuisen, D.J.6
  • 40
    • 84867578067 scopus 로고    scopus 로고
    • Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: the MARKED (Multi mARKer Emergency Dyspnea)-risk score
    • Eurlings L.W., Sanders-van Wijk S., van Kimmenade R., Osinski A., van Helmond L., Vallinga M., et al. Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: the MARKED (Multi mARKer Emergency Dyspnea)-risk score. J Am Coll Cardiol Oct 23 2012, 60(17):1668-1677.
    • (2012) J Am Coll Cardiol , vol.60 , Issue.17 , pp. 1668-1677
    • Eurlings, L.W.1    Sanders-van Wijk, S.2    van Kimmenade, R.3    Osinski, A.4    van Helmond, L.5    Vallinga, M.6
  • 41
    • 84870482586 scopus 로고    scopus 로고
    • Galectin 3 complements BNP in risk stratification in acute heart failure
    • Fermann G.J., Lindsell C.J., Storrow A.B., Hart K., Sperling M., Roll S., et al. Galectin 3 complements BNP in risk stratification in acute heart failure. Biomarkers Dec 2012, 17(8):706-713.
    • (2012) Biomarkers , vol.17 , Issue.8 , pp. 706-713
    • Fermann, G.J.1    Lindsell, C.J.2    Storrow, A.B.3    Hart, K.4    Sperling, M.5    Roll, S.6
  • 42
    • 84904801975 scopus 로고    scopus 로고
    • Usefulness of combining galectin-3 and BIVA assessments in predicting short- and long-term events in patients admitted for acute heart failure
    • De Berardinis B., Magrini L., Zampini G., Zancla B., Salerno G., Cardelli P., et al. Usefulness of combining galectin-3 and BIVA assessments in predicting short- and long-term events in patients admitted for acute heart failure. Biomed Res Int 2014, 2014:983098.
    • (2014) Biomed Res Int , vol.2014 , pp. 983098
    • De Berardinis, B.1    Magrini, L.2    Zampini, G.3    Zancla, B.4    Salerno, G.5    Cardelli, P.6
  • 43
    • 84880072700 scopus 로고    scopus 로고
    • Biological variation of galectin-3 and soluble ST2 for chronic heart failure: implication on interpretation of test results
    • Wu A.H., Wians F., Jaffe A. Biological variation of galectin-3 and soluble ST2 for chronic heart failure: implication on interpretation of test results. Am Heart J Jun 2013, 165(6):995-999.
    • (2013) Am Heart J , vol.165 , Issue.6 , pp. 995-999
    • Wu, A.H.1    Wians, F.2    Jaffe, A.3
  • 44
    • 84877106997 scopus 로고    scopus 로고
    • Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT
    • Anand I.S., Rector T.S., Kuskowski M., Adourian A., Muntendam P., Cohn J.N. Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT. Eur J Heart Fail May 2013, 15(5):511-518.
    • (2013) Eur J Heart Fail , vol.15 , Issue.5 , pp. 511-518
    • Anand, I.S.1    Rector, T.S.2    Kuskowski, M.3    Adourian, A.4    Muntendam, P.5    Cohn, J.N.6
  • 45
    • 84885044150 scopus 로고    scopus 로고
    • Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study
    • Motiwala S.R., Szymonifka J., Belcher A., Weiner R.B., Baggish A.L., Sluss P., et al. Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. Eur J Heart Fail Oct 2013, 15(10):1157-1163.
    • (2013) Eur J Heart Fail , vol.15 , Issue.10 , pp. 1157-1163
    • Motiwala, S.R.1    Szymonifka, J.2    Belcher, A.3    Weiner, R.B.4    Baggish, A.L.5    Sluss, P.6
  • 46
    • 70349975735 scopus 로고    scopus 로고
    • The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients
    • Lin Y.H., Lin L.Y., Wu Y.W., Chien K.L., Lee C.M., Hsu R.B., et al. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients. Clin Chim Acta Nov 2009, 409(1-2):96-99.
    • (2009) Clin Chim Acta , vol.409 , Issue.1-2 , pp. 96-99
    • Lin, Y.H.1    Lin, L.Y.2    Wu, Y.W.3    Chien, K.L.4    Lee, C.M.5    Hsu, R.B.6
  • 47
    • 77954658143 scopus 로고    scopus 로고
    • Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
    • Lok D.J., Van Der Meer P., de la Porte P.W., Lipsic E., Van Wijngaarden J., Hillege H.L., et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol May 2010, 99(5):323-328.
    • (2010) Clin Res Cardiol , vol.99 , Issue.5 , pp. 323-328
    • Lok, D.J.1    Van Der Meer, P.2    de la Porte, P.W.3    Lipsic, E.4    Van Wijngaarden, J.5    Hillege, H.L.6
  • 48
    • 84876134473 scopus 로고    scopus 로고
    • Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure
    • Lok D.J., Lok S.I., Bruggink-Andre de la Porte P.W., Badings E., Lipsic E., van Wijngaarden J., et al. Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure. Clin Res Cardiol Feb 2013, 102(2):103-110.
    • (2013) Clin Res Cardiol , vol.102 , Issue.2 , pp. 103-110
    • Lok, D.J.1    Lok, S.I.2    Bruggink-Andre de la Porte, P.W.3    Badings, E.4    Lipsic, E.5    van Wijngaarden, J.6
  • 49
    • 84859639923 scopus 로고    scopus 로고
    • Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study
    • Felker G.M., Fiuzat M., Shaw L.K., Clare R., Whellan D.J., Bettari L., et al. Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study. Circ Heart Fail Jan 2012, 5(1):72-78.
    • (2012) Circ Heart Fail , vol.5 , Issue.1 , pp. 72-78
    • Felker, G.M.1    Fiuzat, M.2    Shaw, L.K.3    Clare, R.4    Whellan, D.J.5    Bettari, L.6
  • 50
    • 84901658442 scopus 로고    scopus 로고
    • Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure
    • Ahmad T., Fiuzat M., Neely B., Neely M.L., Pencina M.J., Kraus W.E., et al. Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure. JACC Heart Fail Jun 2014, 2(3):260-268.
    • (2014) JACC Heart Fail , vol.2 , Issue.3 , pp. 260-268
    • Ahmad, T.1    Fiuzat, M.2    Neely, B.3    Neely, M.L.4    Pencina, M.J.5    Kraus, W.E.6
  • 51
    • 84870300941 scopus 로고    scopus 로고
    • The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
    • Gullestad L., Ueland T., Kjekshus J., Nymo S.H., Hulthe J., Muntendam P., et al. The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Am Heart J Dec 2012, 164(6):878-883.
    • (2012) Am Heart J , vol.164 , Issue.6 , pp. 878-883
    • Gullestad, L.1    Ueland, T.2    Kjekshus, J.3    Nymo, S.H.4    Hulthe, J.5    Muntendam, P.6
  • 52
    • 79960350455 scopus 로고    scopus 로고
    • Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival
    • Tang W.H., Shrestha K., Shao Z., Borowski A.G., Troughton R.W., Thomas J.D., et al. Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival. Am J Cardiol Aug 1 2011, 108(3):385-390.
    • (2011) Am J Cardiol , vol.108 , Issue.3 , pp. 385-390
    • Tang, W.H.1    Shrestha, K.2    Shao, Z.3    Borowski, A.G.4    Troughton, R.W.5    Thomas, J.D.6
  • 53
    • 84892415130 scopus 로고    scopus 로고
    • Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3
    • Bayes-Genis A., de Antonio M., Vila J., Penafiel J., Galan A., Barallat J., et al. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3. J Am Coll Cardiol Jan 21 2014, 63(2):158-166.
    • (2014) J Am Coll Cardiol , vol.63 , Issue.2 , pp. 158-166
    • Bayes-Genis, A.1    de Antonio, M.2    Vila, J.3    Penafiel, J.4    Galan, A.5    Barallat, J.6
  • 54
    • 84995363390 scopus 로고    scopus 로고
    • EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population
    • Nieminen M.S., Brutsaert D., Dickstein K., Drexler H., Follath F., Harjola V.P., et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J Nov 2006, 27(22):2725-2736.
    • (2006) Eur Heart J , vol.27 , Issue.22 , pp. 2725-2736
    • Nieminen, M.S.1    Brutsaert, D.2    Dickstein, K.3    Drexler, H.4    Follath, F.5    Harjola, V.P.6
  • 55
    • 84856072702 scopus 로고    scopus 로고
    • Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22
    • Grandin E.W., Jarolim P., Murphy S.A., Ritterova L., Cannon C.P., Braunwald E., et al. Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22. Clin Chem Jan 2012, 58(1):267-273.
    • (2012) Clin Chem , vol.58 , Issue.1 , pp. 267-273
    • Grandin, E.W.1    Jarolim, P.2    Murphy, S.A.3    Ritterova, L.4    Cannon, C.P.5    Braunwald, E.6
  • 56
    • 84866729958 scopus 로고    scopus 로고
    • Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community
    • Ho J.E., Liu C., Lyass A., Courchesne P., Pencina M.J., Vasan R.S., et al. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol Oct 2 2012, 60(14):1249-1256.
    • (2012) J Am Coll Cardiol , vol.60 , Issue.14 , pp. 1249-1256
    • Ho, J.E.1    Liu, C.2    Lyass, A.3    Courchesne, P.4    Pencina, M.J.5    Vasan, R.S.6
  • 58
    • 84920131848 scopus 로고    scopus 로고
    • Clinical risk stratification optimizes value of biomarkers to predict new onset heart failure in a community-based cohort
    • Brouwers F.P., van Gilst W.H., Damman K., van den Berg M., Gansevoort R.T., Bakker S.J., et al. Clinical risk stratification optimizes value of biomarkers to predict new onset heart failure in a community-based cohort. Circ Heart Fail Sep 2014, 7(5):723-731.
    • (2014) Circ Heart Fail Sep , vol.7 , Issue.5 , pp. 723-731
    • Brouwers, F.P.1    van Gilst, W.H.2    Damman, K.3    van den Berg, M.4    Gansevoort, R.T.5    Bakker, S.J.6
  • 59
    • 84899539214 scopus 로고    scopus 로고
    • Galectin 3 and incident atrial fibrillation in the community
    • Ho J.E., Yin X., Levy D., Vasan R.S., Magnani J.W., Ellinor P.T., et al. Galectin 3 and incident atrial fibrillation in the community. Am Heart J May 2014, 167(5):729-734. [e1.].
    • (2014) Am Heart J , vol.167 , Issue.5 , pp. 729-734
    • Ho, J.E.1    Yin, X.2    Levy, D.3    Vasan, R.S.4    Magnani, J.W.5    Ellinor, P.T.6
  • 60
    • 84899548228 scopus 로고    scopus 로고
    • Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study
    • Daniels L.B., Clopton P., Laughlin G.A., Maisel A.S., Barrett-Connor E. Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study. Am Heart J May 2014, 167(5):674-682. [e1.].
    • (2014) Am Heart J , vol.167 , Issue.5 , pp. 674-682
    • Daniels, L.B.1    Clopton, P.2    Laughlin, G.A.3    Maisel, A.S.4    Barrett-Connor, E.5
  • 61
    • 84890354566 scopus 로고    scopus 로고
    • The association between galectin-3 and clinical parameters in patients with fi rst acute myocardial infarction treated with primary percutaneous coronary angioplasty
    • Szadkowska I., Wlazel R.N., Migala M., Szadkowski K., Zielinska M., Paradowski M., et al. The association between galectin-3 and clinical parameters in patients with fi rst acute myocardial infarction treated with primary percutaneous coronary angioplasty. Cardiol J 2013, 20(6):577-582.
    • (2013) Cardiol J , vol.20 , Issue.6 , pp. 577-582
    • Szadkowska, I.1    Wlazel, R.N.2    Migala, M.3    Szadkowski, K.4    Zielinska, M.5    Paradowski, M.6
  • 63
    • 84876406373 scopus 로고    scopus 로고
    • Using biomarkers to "guide" heart failure management: current perspectives and future directions
    • Motiwala S.R., Januzzi J.L. Using biomarkers to "guide" heart failure management: current perspectives and future directions. Cardiol Rev May-Jun 2013, 21(3):127-134.
    • (2013) Cardiol Rev , vol.21 , Issue.3 , pp. 127-134
    • Motiwala, S.R.1    Januzzi, J.L.2
  • 64
    • 84868303470 scopus 로고    scopus 로고
    • Use of biomarkers to guide outpatient therapy of heart failure
    • DeBeradinis B., Januzzi J.L. Use of biomarkers to guide outpatient therapy of heart failure. Curr Opin Cardiol Nov 2012, 27(6):661-668.
    • (2012) Curr Opin Cardiol , vol.27 , Issue.6 , pp. 661-668
    • DeBeradinis, B.1    Januzzi, J.L.2
  • 65
    • 84892642395 scopus 로고    scopus 로고
    • Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION
    • Fiuzat M., Schulte P.J., Felker M., Ahmad T., Neely M., Adams K.F., et al. Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION. J Card Fail Jan 2014, 20(1):38-44.
    • (2014) J Card Fail , vol.20 , Issue.1 , pp. 38-44
    • Fiuzat, M.1    Schulte, P.J.2    Felker, M.3    Ahmad, T.4    Neely, M.5    Adams, K.F.6
  • 66
    • 84901985918 scopus 로고    scopus 로고
    • Osteopontin and galectin-3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators
    • Francia P., Adduci C., Semprini L., Borro M., Ricotta A., Sensini I., et al. Osteopontin and galectin-3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators. J Cardiovasc Electrophysiol Jun 2014, 25(6):609-616.
    • (2014) J Cardiovasc Electrophysiol , vol.25 , Issue.6 , pp. 609-616
    • Francia, P.1    Adduci, C.2    Semprini, L.3    Borro, M.4    Ricotta, A.5    Sensini, I.6
  • 67
    • 84919811777 scopus 로고    scopus 로고
    • Practical experience using galectin-3 in heart failure
    • McCullough P.A. Practical experience using galectin-3 in heart failure. Clin Chem Lab Med Oct 2014, 52(10):1425-1431.
    • (2014) Clin Chem Lab Med , vol.52 , Issue.10 , pp. 1425-1431
    • McCullough, P.A.1
  • 68
    • 84884294190 scopus 로고    scopus 로고
    • 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • Yancy C.W., Jessup M., Bozkurt B., Butler J., Casey D.E., Drazner M.H., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol Oct 15 2013, 62(16):e147-e239.
    • (2013) J Am Coll Cardiol , vol.62 , Issue.16 , pp. e147-e239
    • Yancy, C.W.1    Jessup, M.2    Bozkurt, B.3    Butler, J.4    Casey, D.E.5    Drazner, M.H.6
  • 70
    • 79954479056 scopus 로고    scopus 로고
    • Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury
    • Kolatsi-Joannou M., Price K.L., Winyard P.J., Long D.A. Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury. PLoS One Apr 8 2011, 6(4):e18683.
    • (2011) PLoS One , vol.6 , Issue.4 , pp. e18683
    • Kolatsi-Joannou, M.1    Price, K.L.2    Winyard, P.J.3    Long, D.A.4
  • 73
    • 1542373593 scopus 로고    scopus 로고
    • Expression of galectins in cancer: a critical review
    • van den Brule F., Califice S., Castronovo V. Expression of galectins in cancer: a critical review. Glycoconj J 2004, 19(7-9):537-542.
    • (2004) Glycoconj J , vol.19 , Issue.7-9 , pp. 537-542
    • van den Brule, F.1    Califice, S.2    Castronovo, V.3
  • 74
    • 11144241063 scopus 로고    scopus 로고
    • Galectins as modulators of tumour progression
    • Liu F.T., Rabinovich G.A. Galectins as modulators of tumour progression. Nat Rev Cancer Jan 2005, 5(1):29-41.
    • (2005) Nat Rev Cancer , vol.5 , Issue.1 , pp. 29-41
    • Liu, F.T.1    Rabinovich, G.A.2
  • 76
    • 84921353607 scopus 로고    scopus 로고
    • Structural myocardial alterations in diabetes and hypertension: the role of galectin-3
    • Seferovic J.P., Lalic N.M., Floridi F., Tesic M., Seferovic P.M., Giga V., et al. Structural myocardial alterations in diabetes and hypertension: the role of galectin-3. Clin Chem Lab Med Oct 2014, 52(10):1499-1505.
    • (2014) Clin Chem Lab Med , vol.52 , Issue.10 , pp. 1499-1505
    • Seferovic, J.P.1    Lalic, N.M.2    Floridi, F.3    Tesic, M.4    Seferovic, P.M.5    Giga, V.6
  • 77
    • 84902244318 scopus 로고    scopus 로고
    • Comparative study of galectin-3 and B-type natriuretic peptide as biomarkers for the diagnosis of heart failure
    • Yin Q.S., Shi B., Dong L., Bi L. Comparative study of galectin-3 and B-type natriuretic peptide as biomarkers for the diagnosis of heart failure. J Geriatr Cardiol Mar 2014, 11(1):79-82.
    • (2014) J Geriatr Cardiol , vol.11 , Issue.1 , pp. 79-82
    • Yin, Q.S.1    Shi, B.2    Dong, L.3    Bi, L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.